Global Eculizumab Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 118602
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Chemical and Material
Buy @ $3500

The Eculizumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Eculizumab market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. PNH accounting for % of the Eculizumab global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Plasma Exchange segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Eculizumab include Alexion, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Eculizumab market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Plasma Exchange

Plasma Infusion

Market segment by Application can be divided into

PNH

aHUS

Other

The key market players for global Eculizumab market are listed below:

Alexion

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Eculizumab product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Eculizumab, with price, sales, revenue and global market share of Eculizumab from 2019 to 2022.

Chapter 3, the Eculizumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Eculizumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Eculizumab market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Eculizumab.

Chapter 13, 14, and 15, to describe Eculizumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Eculizumab Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Eculizumab Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Plasma Exchange

1.2.3 Plasma Infusion

1.3 Market Analysis by Application

1.3.1 Overview: Global Eculizumab Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 PNH

1.3.3 aHUS

1.3.4 Other

1.4 Global Eculizumab Market Size & Forecast

1.4.1 Global Eculizumab Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Eculizumab Sales in Volume (2017-2028)

1.4.3 Global Eculizumab Price (2017-2028)

1.5 Global Eculizumab Production Capacity Analysis

1.5.1 Global Eculizumab Total Production Capacity (2017-2028)

1.5.2 Global Eculizumab Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Eculizumab Market Drivers

1.6.2 Eculizumab Market Restraints

1.6.3 Eculizumab Trends Analysis

2 Manufacturers Profiles

2.1 Alexion

2.1.1 Alexion Details

2.1.2 Alexion Major Business

2.1.3 Alexion Eculizumab Product and Services

2.1.4 Alexion Eculizumab Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Eculizumab Breakdown Data by Manufacturer

3.1 Global Eculizumab Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Eculizumab Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Eculizumab

3.4 Market Concentration Rate

3.4.1 Top 3 Eculizumab Manufacturer Market Share in 2021

3.4.2 Top 6 Eculizumab Manufacturer Market Share in 2021

3.5 Global Eculizumab Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Eculizumab Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Eculizumab Market Size by Region

4.1.1 Global Eculizumab Sales in Volume by Region (2017-2028)

4.1.2 Global Eculizumab Revenue by Region (2017-2028)

4.2 North America Eculizumab Revenue (2017-2028)

4.3 Europe Eculizumab Revenue (2017-2028)

4.4 Asia-Pacific Eculizumab Revenue (2017-2028)

4.5 South America Eculizumab Revenue (2017-2028)

4.6 Middle East and Africa Eculizumab Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Eculizumab Sales in Volume by Type (2017-2028)

5.2 Global Eculizumab Revenue by Type (2017-2028)

5.3 Global Eculizumab Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Eculizumab Sales in Volume by Application (2017-2028)

6.2 Global Eculizumab Revenue by Application (2017-2028)

6.3 Global Eculizumab Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Eculizumab Sales by Type (2017-2028)

7.2 North America Eculizumab Sales by Application (2017-2028)

7.3 North America Eculizumab Market Size by Country

7.3.1 North America Eculizumab Sales in Volume by Country (2017-2028)

7.3.2 North America Eculizumab Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Eculizumab Sales by Type (2017-2028)

8.2 Europe Eculizumab Sales by Application (2017-2028)

8.3 Europe Eculizumab Market Size by Country

8.3.1 Europe Eculizumab Sales in Volume by Country (2017-2028)

8.3.2 Europe Eculizumab Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Eculizumab Sales by Type (2017-2028)

9.2 Asia-Pacific Eculizumab Sales by Application (2017-2028)

9.3 Asia-Pacific Eculizumab Market Size by Region

9.3.1 Asia-Pacific Eculizumab Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Eculizumab Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Eculizumab Sales by Type (2017-2028)

10.2 South America Eculizumab Sales by Application (2017-2028)

10.3 South America Eculizumab Market Size by Country

10.3.1 South America Eculizumab Sales in Volume by Country (2017-2028)

10.3.2 South America Eculizumab Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Eculizumab Sales by Type (2017-2028)

11.2 Middle East & Africa Eculizumab Sales by Application (2017-2028)

11.3 Middle East & Africa Eculizumab Market Size by Country

11.3.1 Middle East & Africa Eculizumab Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Eculizumab Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Eculizumab and Key Manufacturers

12.2 Manufacturing Costs Percentage of Eculizumab

12.3 Eculizumab Production Process

12.4 Eculizumab Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Eculizumab Typical Distributors

13.3 Eculizumab Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Eculizumab Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Eculizumab Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Alexion Basic Information, Manufacturing Base and Competitors

Table 4. Alexion Major Business

Table 5. Alexion Eculizumab Product and Services

Table 6. Alexion Eculizumab Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Global Eculizumab Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)

Table 8. Global Eculizumab Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 9. Market Position of Manufacturers in Eculizumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 10. Global Eculizumab Production Capacity by Company, (Kg): 2020 VS 2021

Table 11. Head Office and Eculizumab Production Site of Key Manufacturer

Table 12. Eculizumab New Entrant and Capacity Expansion Plans

Table 13. Eculizumab Mergers & Acquisitions in the Past Five Years

Table 14. Global Eculizumab Sales by Region (2017-2022) & (Kg)

Table 15. Global Eculizumab Sales by Region (2023-2028) & (Kg)

Table 16. Global Eculizumab Revenue by Region (2017-2022) & (USD Million)

Table 17. Global Eculizumab Revenue by Region (2023-2028) & (USD Million)

Table 18. Global Eculizumab Sales by Type (2017-2022) & (Kg)

Table 19. Global Eculizumab Sales by Type (2023-2028) & (Kg)

Table 20. Global Eculizumab Revenue by Type (2017-2022) & (USD Million)

Table 21. Global Eculizumab Revenue by Type (2023-2028) & (USD Million)

Table 22. Global Eculizumab Price by Type (2017-2022) & (USD/Kg)

Table 23. Global Eculizumab Price by Type (2023-2028) & (USD/Kg)

Table 24. Global Eculizumab Sales by Application (2017-2022) & (Kg)

Table 25. Global Eculizumab Sales by Application (2023-2028) & (Kg)

Table 26. Global Eculizumab Revenue by Application (2017-2022) & (USD Million)

Table 27. Global Eculizumab Revenue by Application (2023-2028) & (USD Million)

Table 28. Global Eculizumab Price by Application (2017-2022) & (USD/Kg)

Table 29. Global Eculizumab Price by Application (2023-2028) & (USD/Kg)

Table 30. North America Eculizumab Sales by Country (2017-2022) & (Kg)

Table 31. North America Eculizumab Sales by Country (2023-2028) & (Kg)

Table 32. North America Eculizumab Revenue by Country (2017-2022) & (USD Million)

Table 33. North America Eculizumab Revenue by Country (2023-2028) & (USD Million)

Table 34. North America Eculizumab Sales by Type (2017-2022) & (Kg)

Table 35. North America Eculizumab Sales by Type (2023-2028) & (Kg)

Table 36. North America Eculizumab Sales by Application (2017-2022) & (Kg)

Table 37. North America Eculizumab Sales by Application (2023-2028) & (Kg)

Table 38. Europe Eculizumab Sales by Country (2017-2022) & (Kg)

Table 39. Europe Eculizumab Sales by Country (2023-2028) & (Kg)

Table 40. Europe Eculizumab Revenue by Country (2017-2022) & (USD Million)

Table 41. Europe Eculizumab Revenue by Country (2023-2028) & (USD Million)

Table 42. Europe Eculizumab Sales by Type (2017-2022) & (Kg)

Table 43. Europe Eculizumab Sales by Type (2023-2028) & (Kg)

Table 44. Europe Eculizumab Sales by Application (2017-2022) & (Kg)

Table 45. Europe Eculizumab Sales by Application (2023-2028) & (Kg)

Table 46. Asia-Pacific Eculizumab Sales by Region (2017-2022) & (Kg)

Table 47. Asia-Pacific Eculizumab Sales by Region (2023-2028) & (Kg)

Table 48. Asia-Pacific Eculizumab Revenue by Region (2017-2022) & (USD Million)

Table 49. Asia-Pacific Eculizumab Revenue by Region (2023-2028) & (USD Million)

Table 50. Asia-Pacific Eculizumab Sales by Type (2017-2022) & (Kg)

Table 51. Asia-Pacific Eculizumab Sales by Type (2023-2028) & (Kg)

Table 52. Asia-Pacific Eculizumab Sales by Application (2017-2022) & (Kg)

Table 53. Asia-Pacific Eculizumab Sales by Application (2023-2028) & (Kg)

Table 54. South America Eculizumab Sales by Country (2017-2022) & (Kg)

Table 55. South America Eculizumab Sales by Country (2023-2028) & (Kg)

Table 56. South America Eculizumab Revenue by Country (2017-2022) & (USD Million)

Table 57. South America Eculizumab Revenue by Country (2023-2028) & (USD Million)

Table 58. South America Eculizumab Sales by Type (2017-2022) & (Kg)

Table 59. South America Eculizumab Sales by Type (2023-2028) & (Kg)

Table 60. South America Eculizumab Sales by Application (2017-2022) & (Kg)

Table 61. South America Eculizumab Sales by Application (2023-2028) & (Kg)

Table 62. Middle East & Africa Eculizumab Sales by Region (2017-2022) & (Kg)

Table 63. Middle East & Africa Eculizumab Sales by Region (2023-2028) & (Kg)

Table 64. Middle East & Africa Eculizumab Revenue by Region (2017-2022) & (USD Million)

Table 65. Middle East & Africa Eculizumab Revenue by Region (2023-2028) & (USD Million)

Table 66. Middle East & Africa Eculizumab Sales by Type (2017-2022) & (Kg)

Table 67. Middle East & Africa Eculizumab Sales by Type (2023-2028) & (Kg)

Table 68. Middle East & Africa Eculizumab Sales by Application (2017-2022) & (Kg)

Table 69. Middle East & Africa Eculizumab Sales by Application (2023-2028) & (Kg)

Table 70. Eculizumab Raw Material

Table 71. Key Manufacturers of Eculizumab Raw Materials

Table 72. Direct Channel Pros & Cons

Table 73. Indirect Channel Pros & Cons

Table 74. Eculizumab Typical Distributors

Table 75. Eculizumab Typical Customers

List of Figures

Figure 1. Eculizumab Picture

Figure 2. Global Eculizumab Revenue Market Share by Type in 2021

Figure 3. Plasma Exchange

Figure 4. Plasma Infusion

Figure 5. Global Eculizumab Revenue Market Share by Application in 2021

Figure 6. PNH

Figure 7. aHUS

Figure 8. Other

Figure 9. Global Eculizumab Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028

Figure 10. Global Eculizumab Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Eculizumab Sales (2017-2028) & (Kg)

Figure 12. Global Eculizumab Price (2017-2028) & (USD/Kg)

Figure 13. Global Eculizumab Production Capacity (2017-2028) & (Kg)

Figure 14. Global Eculizumab Production Capacity by Geographic Region: 2022 VS 2028

Figure 15. Eculizumab Market Drivers

Figure 16. Eculizumab Market Restraints

Figure 17. Eculizumab Market Trends

Figure 18. Global Eculizumab Sales Market Share by Manufacturer in 2021

Figure 19. Global Eculizumab Revenue Market Share by Manufacturer in 2021

Figure 20. Eculizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 21. Top 3 Eculizumab Manufacturer (Revenue) Market Share in 2021

Figure 22. Top 6 Eculizumab Manufacturer (Revenue) Market Share in 2021

Figure 23. Global Eculizumab Sales Market Share by Region (2017-2028)

Figure 24. Global Eculizumab Revenue Market Share by Region (2017-2028)

Figure 25. North America Eculizumab Revenue (2017-2028) & (USD Million)

Figure 26. Europe Eculizumab Revenue (2017-2028) & (USD Million)

Figure 27. Asia-Pacific Eculizumab Revenue (2017-2028) & (USD Million)

Figure 28. South America Eculizumab Revenue (2017-2028) & (USD Million)

Figure 29. Middle East & Africa Eculizumab Revenue (2017-2028) & (USD Million)

Figure 30. Global Eculizumab Sales Market Share by Type (2017-2028)

Figure 31. Global Eculizumab Revenue Market Share by Type (2017-2028)

Figure 32. Global Eculizumab Price by Type (2017-2028) & (USD/Kg)

Figure 33. Global Eculizumab Sales Market Share by Application (2017-2028)

Figure 34. Global Eculizumab Revenue Market Share by Application (2017-2028)

Figure 35. Global Eculizumab Price by Application (2017-2028) & (USD/Kg)

Figure 36. North America Eculizumab Sales Market Share by Type (2017-2028)

Figure 37. North America Eculizumab Sales Market Share by Application (2017-2028)

Figure 38. North America Eculizumab Sales Market Share by Country (2017-2028)

Figure 39. North America Eculizumab Revenue Market Share by Country (2017-2028)

Figure 40. United States Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Canada Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Mexico Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Europe Eculizumab Sales Market Share by Type (2017-2028)

Figure 44. Europe Eculizumab Sales Market Share by Application (2017-2028)

Figure 45. Europe Eculizumab Sales Market Share by Country (2017-2028)

Figure 46. Europe Eculizumab Revenue Market Share by Country (2017-2028)

Figure 47. Germany Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. France Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. United Kingdom Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Russia Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Italy Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Asia-Pacific Eculizumab Sales Market Share by Region (2017-2028)

Figure 53. Asia-Pacific Eculizumab Sales Market Share by Application (2017-2028)

Figure 54. Asia-Pacific Eculizumab Sales Market Share by Region (2017-2028)

Figure 55. Asia-Pacific Eculizumab Revenue Market Share by Region (2017-2028)

Figure 56. China Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Japan Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Korea Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. India Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Southeast Asia Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Australia Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South America Eculizumab Sales Market Share by Type (2017-2028)

Figure 63. South America Eculizumab Sales Market Share by Application (2017-2028)

Figure 64. South America Eculizumab Sales Market Share by Country (2017-2028)

Figure 65. South America Eculizumab Revenue Market Share by Country (2017-2028)

Figure 66. Brazil Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Argentina Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Middle East & Africa Eculizumab Sales Market Share by Type (2017-2028)

Figure 69. Middle East & Africa Eculizumab Sales Market Share by Application (2017-2028)

Figure 70. Middle East & Africa Eculizumab Sales Market Share by Region (2017-2028)

Figure 71. Middle East & Africa Eculizumab Revenue Market Share by Region (2017-2028)

Figure 72. Turkey Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Egypt Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. South Africa Eculizumab Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Manufacturing Cost Structure Analysis of Eculizumab in 2021

Figure 77. Manufacturing Process Analysis of Eculizumab

Figure 78. Eculizumab Industrial Chain

Figure 79. Sales Channel: Direct Channel vs Indirect Channel

Figure 80. Methodology

Figure 81. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz